Market News
Global Artificial Intelligence (AI) Diagnostics Market: Key Developments
- In February 2021, Vuno expanded its business offerings to Taiwanese markets by signing a distribution agreement with CHC Healthcare Group, to hand over marketing and distribution rights of its AI solutions in Taiwan.
- In November 2020, AliveCor, Inc., the company received U.S. FDA approval for its product, Karida AI V2, a next-gen interpretive ECG algorithm. This approval enables the company plan commercialization strategies for the product in the U.S. market.